Generalised blistering in an infant following vaccination

Nandana Chitra Kumar1, Gowri Anur2, Pallavi Hegde2

  • 1Department of Dermatology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.

BMJ Case Reports
|February 2, 2026
PubMed

Insights

A rare case of bullous pemphigoid, an autoimmune skin condition, was diagnosed in an infant following pentavalent vaccination. The infant responded well to treatment and tolerated subsequent vaccine doses without recurrence.

Area of Science:

  • Pediatric Dermatology
  • Immunology
  • Vaccinology

Background:

  • Bullous pemphigoid (BP) is a rare autoimmune blistering disease.
  • While typically affecting the elderly, rare cases have been reported in children.
  • The potential association between vaccinations and autoimmune conditions is an area of ongoing research.

Purpose of the Study:

  • To report a case of bullous pemphigoid in an infant.
  • To investigate the potential link between pentavalent vaccination and the onset of bullous pemphigoid.
  • To describe the management and outcome of this rare pediatric case.

Main Methods:

  • Clinical presentation of a male infant with itchy, fluid-filled lesions.
  • Immunological tests to confirm the diagnosis of bullous pemphigoid.
  • Treatment regimen including corticosteroids and dapsone.

Main Results:

  • The infant presented with characteristic "string-of-pearl" lesions post-vaccination.
  • Diagnosis of bullous pemphigoid was immunologically confirmed.
  • Successful treatment with corticosteroids and dapsone led to significant improvement.
  • Subsequent vaccine doses were administered without relapse.

Conclusions:

  • Pentavalent vaccination may be a potential trigger for bullous pemphigoid in susceptible infants.
  • Early diagnosis and appropriate treatment are crucial for managing pediatric bullous pemphigoid.
  • The safety of continued vaccination schedules in such cases was demonstrated.